Gritstone Bio Analyst Ratings
Gritstone Bio Analyst Ratings
Gritstone 生物分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 488.24% | Piper Sandler | $6 → $7 | Maintains | Overweight |
| 08/10/2023 | 488.24% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/15/2023 | 488.24% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/28/2023 | 572.27% | B. Riley Securities | → $8 | Initiates Coverage On | → Buy |
| 03/14/2023 | 488.24% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/15/2023 | 488.24% | HC Wainwright & Co. | → $7 | Maintains | Buy |
| 11/07/2022 | 488.24% | HC Wainwright & Co. | $12 → $7 | Maintains | Buy |
| 10/31/2022 | 404.2% | Piper Sandler | → $6 | Initiates Coverage On | → Overweight |
| 08/22/2022 | 68.07% | Goldman Sachs | → $2 | Downgrades | Neutral → Sell |
| 05/09/2022 | 908.4% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/14/2022 | 1160.5% | HC Wainwright & Co. | $24 → $15 | Maintains | Buy |
| 01/20/2021 | 572.27% | Baird | → $8 | Downgrades | Outperform → Underperform |
| 01/20/2021 | 1916.81% | HC Wainwright & Co. | $16 → $24 | Maintains | Buy |
| 07/14/2020 | 1328.57% | BTIG | $31 → $17 | Maintains | Buy |
| 07/26/2019 | 1328.57% | Baird | → $17 | Initiates Coverage On | → Outperform |
| 03/15/2019 | 1580.67% | Raymond James | → $20 | Initiates Coverage On | → Outperform |
| 03/07/2019 | 1328.57% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 10/23/2018 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 10/23/2018 | 1412.61% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 10/23/2018 | 2084.87% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 10/23/2018 | 2000.84% | Barclays | → $25 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/28/2023 | 488.24% | 派珀·桑德勒 | $6→$7 | 維護 | 超重 |
| 2023年08月10日 | 488.24% | HC Wainwright公司 | →$7 | 重申 | 購買→購買 |
| 2023年05月15日 | 488.24% | HC Wainwright公司 | →$7 | 重申 | 購買→購買 |
| 03/28/2023 | 572.27% | B.萊利證券 | →$8 | 開始承保 | →購買 |
| 03/14/2023 | 488.24% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 02/15/2023 | 488.24% | HC Wainwright公司 | →$7 | 維護 | 買 |
| 11/07/2022 | 488.24% | HC Wainwright公司 | $12→$7 | 維護 | 買 |
| 2022年10月31日 | 404.2% | 派珀·桑德勒 | →$6 | 開始承保 | →超重 |
| 2022/08/22 | 68.07% | 高盛 | →$2 | 評級下調 | 中性→銷售 |
| 05/09/2022 | 908.4% | HC Wainwright公司 | $15→$12 | 維護 | 買 |
| 03/14/2022 | 1160.5% | HC Wainwright公司 | $24→$15 | 維護 | 買 |
| 01/20/2021 | 572.27% | 貝爾德 | →$8 | 評級下調 | 跑贏→表現不佳 |
| 01/20/2021 | 1916.81% | HC Wainwright公司 | $16→$24 | 維護 | 買 |
| 07/14/2020 | 1328.57% | BTIG | $31→$17 | 維護 | 買 |
| 2019年07月26日 | 1328.57% | 貝爾德 | →$17 | 開始承保 | →跑贏大盤 |
| 2019年03月15日 | 1580.67% | 雷蒙德·詹姆斯 | →$20 | 開始承保 | →跑贏大盤 |
| 2019年07月03日 | 1328.57% | HC Wainwright公司 | →$17 | 開始承保 | →購買 |
| 2018年10月23日 | - | 考恩公司 | 開始承保 | →跑贏大盤 | |
| 2018年10月23日 | 1412.61% | 高盛 | →$18 | 開始承保 | →中性 |
| 2018年10月23日 | 2084.87% | BTIG | →$26 | 開始承保 | →購買 |
| 2018年10月23日 | 2000.84% | 巴克萊 | →$25 | 開始承保 | →超重 |
What is the target price for Gritstone Bio (GRTS)?
格裡斯通生物公司(Gritstone Bio)的目標價是多少？
There is no price target for Gritstone Bio
Gritstone Bio沒有目標價格
What is the most recent analyst rating for Gritstone Bio (GRTS)?
分析師對Gritstone Bio的最新評級是多少？
There is no analyst for Gritstone Bio
Gritstone Bio沒有分析師
When is the next analyst rating going to be posted or updated for Gritstone Bio (GRTS)?
格裡斯通生物(GRTS)的下一次分析師評級將於何時發佈或更新？
There is no next analyst rating for Gritstone Bio
Gritstone Bio沒有下一個分析師評級
Is the Analyst Rating Gritstone Bio (GRTS) correct?
分析師對Gritstone Bio的評級正確嗎？
There is no next analyst rating for Gritstone Bio
Gritstone Bio沒有下一個分析師評級